Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Department of Defense, through the Defense Logistics Agency, has issued a contract opportunity for Pramipexole di-HCl. The latest modifications, P00006 and P00005, include incorporating Drug Supply Chain Security Act language and FAR 52.204-27 clause regarding ByteDance Covered Application prohibition. Modification P00004, SPE2D220D0091, has been issued to invoke Option 3 effective from April 29, 2023, through April 28.
Pramipexole di-HCl
Modification SPE2D220D0091 P00006 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract.
Modification SPE2D220D0091 P00005 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract.
Modification P00004 SPE2D220D0091 issued to Invoke Option 3 effective April 29, 2023 through April 28, 2024.
Modification P00003 SPE2D220D0091 issued to Invoke Option 2 effective April 29, 2022 through April 28, 2023.
Modification P00002 SPE2D220D0091 issued to Invoke Option 1 effective April 29, 2021 through April 28, 2022.
Modification P00001 SPE2D220D0091 to incorporate FAR 52.204-24 and FAR 52.205-25 into contract.
Amendment 0006 SPE2D2-19-R-0051 Pramipexole di-HCl to extend the closing date to December 31, 2019 at 3:00 PM EST. To correct page 4 of solicaiiton block 9; titled, Submisssion Instructions for "hand carried" offers building number. To corect pages 29-30 for the "Statement of Work" of solicitation. To incorporate FAR Clause 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment into the solicitation.
PRAMIPEXOLE DI-HCL is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.